Common Contracts
2 similar Second Letter Agreement Regarding Unsecured Note contracts by NKGen Biotech, Inc.
SECOND LETTER AGREEMENT REGARDING UNSECURED NOTESecond Letter Agreement Regarding Unsecured Note • August 9th, 2024 • NKGen Biotech, Inc. • Biological products, (no disgnostic substances) • Delaware
This Second Letter Agreement (“Letter”), dated as of August 7, 2024, is made between Meteora Select Trading Opportunities Master, LP, Meteora Capital Partners, LP and Meteora Strategic Capital, LLC (collectively, “Lender”) and NKGEN BIOTECH, INC. (“Borrower”).
SECOND LETTER AGREEMENT REGARDING UNSECURED NOTESecond Letter Agreement Regarding Unsecured Note • August 9th, 2024 • NKGen Biotech, Inc. • Biological products, (no disgnostic substances) • Delaware
This Second Letter Agreement (“Letter “), dated as of August 7, 2024, is made between Sandia Investment Management LP on behalf of Diametric True Alpha Market Neutral Master Fund LP and Diametric True Alpha Enhanced Market Neutral Master Fund LP (collectively, “Lender”) and NKGEN BIOTECH, INC. (“Borrower”).
